Clinical Trial Update: Sofosbuvir Plus Ribavirin, or Ledipasvir/Sofosbuvir in Adults With HCV Infection and Renal Insufficiency [Phase 2]

View source ↗

Summary

Phase 2 trial comparing Sofosbuvir plus Ribavirin versus Ledipasvir/Sofosbuvir in adults with hepatitis C and renal insufficiency; results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Ledipasvir/sofosbuvir (Ledipasvir and sofosbuvir)
• Sofosbuvir + Ribavirin (sofosbuvir; ribavirin)

Snippet

Sponsor: Gilead Sciences | Conditions: HCV Infection | Phase 2 | Status: COMPLETED | Results posted: 2018-08-08